Reina Yajima Selected Research

Reina Yajima Research Topics

Disease

23	Neoplasms (Cancer) 12/2021 - 05/2011
19	Breast Neoplasms (Breast Cancer) 12/2021 - 09/2012
9	Colorectal Neoplasms (Colorectal Cancer) 03/2015 - 09/2011
5	Neoplasm Metastasis (Metastasis) 03/2020 - 08/2013
4	Colonic Neoplasms (Colon Cancer) 11/2019 - 02/2012
4	Lymphatic Metastasis 06/2016 - 01/2012
3	Inflammation (Inflammations) 08/2018 - 07/2014
3	Rectal Neoplasms (Rectal Cancer) 05/2015 - 11/2011
2	Noninfiltrating Intraductal Carcinoma (DCIS) 08/2017 - 01/2017
2	Hyperthermia 06/2014 - 11/2011
2	Primary Hyperparathyroidism 04/2012 - 06/2011
1	Alopecia (Baldness) 03/2021
1	Disease Progression 03/2020
1	Triple Negative Breast Neoplasms 03/2020
1	Ductal Carcinoma 08/2017
1	Rupture 08/2016
1	Carcinogenesis 03/2016
1	Neoplasm Micrometastasis 03/2016
1	Ileus 03/2015
1	Malnutrition (Nutritional Deficiencies) 07/2014
1	Venous Thromboembolism 11/2012
1	Carcinoma (Carcinomatosis) 11/2011
1	Margins of Excision 11/2011
1	Adenoma (Adenomas) 06/2011
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 06/2011
1	Mesothelioma 05/2011
1	Wound Infection (Wound Infections) 05/2011
1	Malignant Mesothelioma 05/2011
1	Infections 05/2011
1	Obesity 01/2010

Drug/Important Bio-Agent (IBA)

6	Indicators and Reagents (Reagents)IBA 08/2018 - 03/2014
5	C-Reactive ProteinIBA 08/2018 - 05/2011
4	Biomarkers (Surrogate Marker)IBA 09/2020 - 01/2016
4	Serum AlbuminIBA 07/2020 - 09/2011
4	Biological ProductsIBA 05/2015 - 07/2011
3	Estrogen ReceptorsIBA 12/2021 - 06/2016
3	AlbuminsIBA 07/2020 - 01/2012
2	ErbB Receptors (EGF Receptor)IBA 12/2021 - 03/2015
2	Phenobarbital (Luminal)FDA Link 12/2021 - 03/2020
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2021 - 11/2020
2	Fluorouracil (Carac)FDA LinkGeneric 03/2021 - 11/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2020 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 07/2014
2	Progesterone Receptors (Progesterone Receptor)IBA 10/2016 - 06/2016
2	Prealbumin (Transthyretin)IBA 07/2014 - 01/2012
1	human ERBB2 proteinIBA 12/2021
1	taxaneIBA 03/2021
1	Epirubicin (Ellence)FDA LinkGeneric 03/2021
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 09/2020
1	Immunologic Factors (Immunomodulators)IBA 09/2020
1	LigandsIBA 09/2020
1	eribulin FDA Link 03/2020
1	StathminIBA 11/2019
1	Tumor Biomarkers (Tumor Markers)IBA 11/2019
1	Glucose (Dextrose)FDA LinkGeneric 08/2018
1	LuciferasesIBA 03/2016
1	Pharmaceutical PreparationsIBA 03/2016
1	Sirolimus (Rapamycin)FDA Link 01/2016
1	Cetuximab (Erbitux)FDA Link 03/2015
1	Bevacizumab (Avastin)FDA Link 05/2014
1	Galectin 3 (LGALS3)IBA 08/2013
1	Fondaparinux (Arixtra)FDA Link 11/2012
1	Parathyroid Hormone (Parathormone)IBA 04/2012
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 02/2012
1	Carcinoembryonic AntigenIBA 01/2012
1	hydroxyethyl methacrylate (HEMA)IBA 11/2011
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2011
1	CdZnTeIBA 06/2011
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 06/2011
1	4-toluenesulfonyl fluoride (TSF)IBA 01/2010

Therapy/Procedure

8	Therapeutics 11/2020 - 05/2011
4	Drug Therapy (Chemotherapy) 03/2021 - 05/2011
3	Mastectomy (Mammectomy) 03/2021 - 09/2012
3	Mammaplasty (Breast Reconstruction) 03/2021 - 09/2012
3	Adjuvant Chemotherapy 03/2021 - 06/2016
2	Neoadjuvant Therapy 07/2016 - 06/2014
2	Lymph Node Excision (Lymph Node Dissection) 04/2016 - 06/2015
1	Time-to-Treatment 03/2020
1	Operative Surgical Procedures 08/2017
1	Colectomy 06/2015
1	Ileostomy 05/2015
1	Chemoradiotherapy 06/2014
1	Induced Hyperthermia (Thermotherapy) 11/2011
1	Semiconductors 06/2011
1	Gamma Cameras (Gamma Camera) 06/2011
1	Laparotomy 05/2011
1	Cytoreduction Surgical Procedures 05/2011